Impact of risk score calculations in choosing front‐line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase
Author:
Affiliation:
1. Hematology and Stem Cell Transplantation Section Division of Hematology/Oncology Department of Medicine Vanderbilt University Medical Center and Veterans Affairs Medical Center Nashville TN USA
Funder
Novartis Pharmaceuticals
Publisher
Wiley
Subject
Hematology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.12356
Reference29 articles.
1. The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
2. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
4. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
5. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FUBP3 regulates chronic myeloid leukaemia progression through PRC2 complex regulated PAK1‐ERK signalling;Journal of Cellular and Molecular Medicine;2022-12-07
2. Priapism as the initial presentation in chronic myeloid leukemia is a red flag sign: A case report;Assam Journal of Internal Medicine;2022
3. Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?;Cancers;2021-08-19
4. Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia;Leukemia & Lymphoma;2021-05-04
5. Evaluation of the Relationship Between Initial Lymphocyte Count and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukaemia Patients;Istanbul Medical Journal;2020-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3